Literature DB >> 17449018

A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.

Wessel P Dirksen1, Veronique A Lacombe, Mei Chi, Anuradha Kalyanasundaram, Serge Viatchenko-Karpinski, Dmitry Terentyev, Zhixiang Zhou, Srikanth Vedamoorthyrao, Ning Li, Nipavan Chiamvimonvat, Cynthia A Carnes, Clara Franzini-Armstrong, Sandor Györke, Muthu Periasamy.   

Abstract

OBJECTIVE: A naturally-occurring mutation in cardiac calsequestrin (CASQ2) at amino acid 307 was discovered in a highly inbred family and hypothesized to cause Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The goal of this study was to establish a causal link between CASQ2(D307H) and the CPVT phenotype using an in vivo model. METHODS AND
RESULTS: Cardiac-specific expression of the CASQ2(D307H) transgene was achieved using the alpha-MHC promoter. Multiple transgenic (TG) mouse lines expressing CASQ2(D307H) from 2- to 6-fold possess structurally normal hearts without any sign of hypertrophy. The hearts displayed normal ventricular function. Myocytes isolated from TG mice had diminished I(Ca)-induced Ca2+ transient amplitude and duration, as well as increased Ca2+ spark frequency. These myocytes, when exposed to isoproterenol and caffeine, displayed disturbances in their rhythmic Ca2+ oscillations and membrane potential, and delayed afterdepolarizations. ECG monitoring revealed that TG mice challenged with isoproterenol and caffeine developed complex ventricular arrhythmias, including non-sustained polymorphic ventricular tachycardia.
CONCLUSIONS: The findings of the present study demonstrate that expression of mutant CASQ2(D307H) in the mouse heart results in abnormal myocyte Ca2+ handling and predisposes to complex ventricular arrhythmias similar to the CPVT phenotype observed in human patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449018      PMCID: PMC2717009          DOI: 10.1016/j.cardiores.2007.03.002

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  42 in total

1.  Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice.

Authors:  Zhao Zhang; Yanfang Xu; Haitao Song; Jennifer Rodriguez; Dipika Tuteja; Yoon Namkung; Hee-Sup Shin; Nipavan Chiamvimonvat
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

2.  Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Héctor H Valdivia; Ariel L Escobar; Sandor Györke
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

3.  Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.

Authors:  P J Laitinen; K M Brown; K Piippo; H Swan; J M Devaney; B Brahmbhatt; E A Donarum; M Marino; N Tiso; M Viitasalo; L Toivonen; D A Stephan; K Kontula
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

4.  Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction.

Authors:  Y M Kobayashi; B A Alseikhan; L R Jones
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

5.  Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

Authors:  H Lahat; M Eldar; E Levy-Nissenbaum; T Bahan; E Friedman; A Khoury; A Lorber; D L Kastner; B Goldman; E Pras
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

6.  Polymerization of calsequestrin. Implications for Ca2+ regulation.

Authors:  HaJeung Park; Si Wu; A Keith Dunker; ChulHee Kang
Journal:  J Biol Chem       Date:  2003-02-19       Impact factor: 5.157

7.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

Review 8.  A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia.

Authors:  Michael Eldar; Elon Pras; Hadas Lahat
Journal:  Trends Cardiovasc Med       Date:  2003-05       Impact factor: 6.677

9.  Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.

Authors:  Wen Zhao; Konrad F Frank; Guoxiang Chu; Michael J Gerst; Albrecht G Schmidt; Yong Ji; Muthu Periasamy; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Silvia G Priori; Carlo Napolitano; Mirella Memmi; Barbara Colombi; Fabrizio Drago; Maurizio Gasparini; Luciano DeSimone; Fernando Coltorti; Raffaella Bloise; Roberto Keegan; Fernando E S Cruz Filho; Gabriele Vignati; Abraham Benatar; Angelica DeLogu
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

View more
  23 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

Review 2.  Altered Ca2+ sparks in aging skeletal and cardiac muscle.

Authors:  Noah Weisleder; Jianjie Ma
Journal:  Ageing Res Rev       Date:  2008-01-05       Impact factor: 10.895

Review 3.  Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.

Authors:  Nicole A Beard; Lan Wei; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-05-12       Impact factor: 1.733

Review 4.  Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.

Authors:  Jeanne M Nerbonne
Journal:  Curr Opin Pharmacol       Date:  2014-03-13       Impact factor: 5.547

5.  Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.

Authors:  Anuradha Kalyanasundaram; Serge Viatchenko-Karpinski; Andriy E Belevych; Veronique A Lacombe; Hyun Seok Hwang; Björn C Knollmann; Sandor Gyorke; Muthu Periasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

Review 6.  Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations.

Authors:  Simon Kochhäuser; Eric Schulze-Bahr; Uwe Kirchhefer
Journal:  Wien Med Wochenschr       Date:  2012-06-25

Review 7.  Genetic variations involved in sudden cardiac death and their associations and interactions.

Authors:  Dazhen Wei; Luyuan Tao; Mingyuan Huang
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 8.  Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence.

Authors:  Zhilin Qu; James N Weiss
Journal:  Annu Rev Physiol       Date:  2014-10-17       Impact factor: 19.318

9.  Multiscale modeling of calcium cycling in cardiac ventricular myocyte: macroscopic consequences of microscopic dyadic function.

Authors:  Namit Gaur; Yoram Rudy
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

10.  The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering.

Authors:  Anuradha Kalyanasundaram; Naresh C Bal; Clara Franzini-Armstrong; Björn C Knollmann; Muthu Periasamy
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.